Mi. Niemeyer et Scr. Lummis, The role of the agonist binding site in Ca2+ inhibition of the recombinant5-HT3A receptor, EUR J PHARM, 428(2), 2001, pp. 153-161
The mechanism and site of action of Ca2+ at the recombinant murine 5-hydrox
ytryptaminee (5-HT),, receptor were investigated using whole-cell voltage c
lamp, radioligand binding and single-cell Ca2+ imaging. Inhibition of the 5
-HT (3 muM)-induced response by 10 muM Ca 2+ reached a plateau at 68.5% inh
ibition, with half-maximal effect at 2.6 mM, This was due to an increase in
EC., from 2.35 to 3.87 LM and a 30% reduction in I-max. Ca2+ also resulted
in the inhibition of binding of both 5-HT3 receptor agonist [H-3]m-cloroph
enylbi [3 2 +) to guanide and antagonist [H-3]granisetron due to an increas
e in K-d with no change in B (max). An increase in EC50, from 2.6 0 mM Ca 4
.7 PM (10 inM Ca2'), with no change in maximal [Ca 2+]i, was observed from
Ca2' imaging studies. Largely similar effects were observed with Mg2'. The
combined data suggest that Ca2+ acting at a site that directly or indirectl
y influences the agonist binding site plays a significant role in its inhib
itory effect at the 5-HT3 receptor. (9 2001 Published by Elsevier Science B
.V.